Riluzole, a Derivative of Benzothiazole as a Potential Anti-Amoebic Agent against <i>Entamoeba histolytica</i>

Amoebiasis is produced by the parasite <i>Entamoeba histolytica</i>; this disease affects millions of people throughout the world who may suffer from amoebic colitis or amoebic liver abscess. Metronidazole is used to treat this protozoan, but it causes important adverse effects that limit its use. S...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Maritza Velásquez-Torres, José Guadalupe Trujillo-Ferrara, Marycarmen Godínez-Victoria, Rosa Adriana Jarillo-Luna, Víctor Tsutsumi, Virginia Sánchez-Monroy, Araceli Posadas-Mondragón, Roberto Issac Cuevas-Hernández, José Angel Santiago-Cruz, Judith Pacheco-Yépez
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-06-01
Edice:	Pharmaceuticals
Témata:	<i>Entamoeba histolytica</i> anti-amoebic activity riluzole benzothiazole
On-line přístup:	https://www.mdpi.com/1424-8247/16/6/896
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!